98%
921
2 minutes
20
Corneal cross-linking (CXL) is an effective method to prevent the progression of keratoconus. CXL combined with hypotonic riboflavin solution is a modified treatment for thin corneas, which are deemed to be below the safe thickness threshold. In this study, rabbit corneas were subjected to different hydration levels using different osmolarity of riboflavin dextran solutions before CXL. Inflation testing was performed to evaluate the corneal biomechanical stiffening effect of hypotonic riboflavin solutions crosslinking. One-month post-CXL, the stromal demarcation line depth (DLD) and the biomechanical property parameter - tangent modulus (Et) - were measured. All CXL groups showed higher Et than the corresponding Ctrl groups (all P < 0.001), however, the Et values showed no statistical differences between the CXL-ed groups with different hydration levels (all P > 0.05). The relative depth ratio of DLD to total corneal thickness (TCT) did not show significant differences (P > 0.05), while the DLD was statistically different in three CXL groups (P < 0.001). The research suggested that riboflavin solutions with different osmolarities are suitable for preoperative swelling of corneas with different thickness ranges. Furthermore, crosslinking with hypotonic riboflavin solutions has no significant effect on corneal biomechanical improvement under a certain degree of hydration.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.exer.2024.110191 | DOI Listing |
ACS Appl Mater Interfaces
September 2025
Department of Ophthalmology, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 321 Zhongshan Road, Nanjing 210008, China.
Pterygium is a common ocular surface lesion, and postoperative recurrence remains a major challenge due to insufficient therapeutic strategies targeting fibroblast proliferation and inflammation. Fibrinogen hydrogel (Fibrin glue, FG), a bioadhesive hydrogel, is widely used in pterygium surgery to secure conjunctival autografts. However, its low adhesion often leads to graft detachment, hindering effective repair.
View Article and Find Full Text PDFSemin Ophthalmol
August 2025
Department of Cornea and Anterior Segment Services, Shantilal Shanghvi Eye Institute, Mumbai, India.
Purpose: Vernal keratoconjunctivitis (VKC) is a chronic, recurrent, allergic ocular surface disorder affecting children and young adults, particularly in tropical climates. Corneal sequelae such as giant papillae (GP), shield ulcers, limbal stem cell deficiency (LSCD), and keratoconus (KC) often necessitate surgical intervention when medical therapy is inadequate. This review summarizes the current surgical strategies for managing VKC-related corneal complications and their outcomes.
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
August 2025
Department of Ophthalmology, the First Affiliated Hospital of Xi'an Jiaotong University, 277 West Yanta Road, Xi'an, Shaanxi 710061, China.
Purpose: To explore the characteristics of corneal biomechanical parameters and corneal thickness in different corneal regions in progressive keratoconus treated by accelerated "epithelium off" cross-linking (A-CXL) surgery.
Methods: This is a retrospective study and is self-controlled before and after surgery. A total of 39 eyes of 25 patients with progressive keratoconus were recruited and treated by A-CXL.
J R Soc Interface
August 2025
Oujiang Laboratory, Wenzhou, Zhejiang, People's Republic of China.
Keratoconus (KC) is a progressive corneal ectasia leading to visual impairment if untreated. Corneal collagen cross-linking (CXL) is an effective treatment to halt KC progression by strengthening corneal biomechanics. However, current CXL treatments lack customization based on regional corneal stiffness, which is crucial for optimal outcomes.
View Article and Find Full Text PDFInt Ophthalmol
August 2025
Translational Ophthalmology Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Purpose: To assess the incidence rate of corneal haze after combined simultaneous photorefractive keratectomy (PRK) and accelerated (10-min, 9 mW/cm) corneal cross-linking (CXL) for non-keratoconus.
Methods: This is a retrospective cohort study on patients without keratoconus underwent simultaneous CXL-PRK. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), manifest refraction, corneal keratometry, and corneal haze were evaluated.